JPRN-UMIN000030297
Recruiting
未知
Investigation of blood-based biomarkers for cardiovascular disease - Kobe Cardiovascular Marker Investigation Registry (Kobe CMI registry)
Division of cardiovascular medicine, Kobe university graduate school of medicine.0 sites2,000 target enrollmentDecember 7, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cardiovascular diseases (Acute coronary syndrome, Arteriosclerotic disease, Valvular heart disease, Chronic heart failure, Arrhythmic disease, Deep vein thrombosis, Pulmonary embolism, Pulmonary hypertension)
- Sponsor
- Division of cardiovascular medicine, Kobe university graduate school of medicine.
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who do not provide written consent for participation in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of novel biomarkers in cardiovascular and metabolic diseaseObesity, hypertension, diabetes, dyslipidemia, ishcemic heart disease, heart failure, renal failureJPRN-UMIN000007095Second Department of Internal Medicine, Sapporo Medical University500
Not yet recruiting
Phase 3
A clinical trial to study the effects of vitamin D and vitamin D plus alpha lipoic acid on cardiovascular complications in type 2 diabetes mellitus patients.Health Condition 1: null- Diabetes associated cardiovascular complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complicationsCTRI/2015/05/005804Manipal University210
Recruiting
Not Applicable
Study of clinical usefulness of blood biomarkers for mild head injurymild traumatic brain injuryJPRN-UMIN000049943International University of Health and Welfare615
Active, not recruiting
Not Applicable
Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitisJPRN-jRCT1050210175Tamagawa-Mineoka Risa15
Completed
Not Applicable
Exploratory study of blood biomarkers to predict the therapeutic effect of nintedanib in idiopathic pulmonary fibrosis (IPF)idiopathic pulmonary fibrosis (IPF)JPRN-UMIN000036457Chiba University Hospital, Respiratory medicine100